NEJM revamps website, adds complete archive

Share this article:
NEJM revamps website, adds complete archive
NEJM revamps website, adds complete archive

The New England Journal of Medicine (NEJM) launched a new website on July 24, including an archive of past issues dating back to 1812.

The revamped website, NEJM.org, incorporates lessons gleaned from the journal's beta site, which tested new functionalities with readers and solicited feedback during 2009. Tom Easley, NEJM's publisher, said the beta site provided user's opinions on things like tabbed articles and image carousels, to determine what works best for readers.

“The primary goal [of the redesign] was to create a unique branded interface, and to make [digital] innovations easier to find for doctors,” said Easley. The new site makes it easier for doctors to access interactive medical case studies, and to use customized specialty areas, he said.

Improvements to the site include a more sophisticated search function, better graphic integration at the article level (after a click, graphics display within the article, instead of prompting a new window or player), and additional levels of customization within the MyNEJM offering, which allows readers to tailor the journal to their specific needs, said Easley. New specialty pages allow doctors to customize alerts and other content that's relevant to their practice areas.

For advertisers, the site offers improved visitor authentication, and provides a more precise targeting capability, said Easley. New sponsorship opportunities include iPhone applications and article tools, among others. New ad formats, such as a half page layout, are also available, per Easley.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...